Similarly, these peptides have decreased glomerular mesangial expansion, extracellular matrix accumulation, monocyte/macrophage deposition, TGF-β expression (inhibited only by endostatin), and type IV collagen expression which are potential pathological events induced in diabetic nephropathy. This evidence concerns the gene TGFB1 and diabetic kidney disease.